Bookmark

Add to MyYahoo RSS

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

3 hrs ago | Freshnews

Medication Non-Adherence Issue Highlighted in Annals of Internal...

MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to medication non-adherence and hospital readmission rates specified in a study published in a recent issue of the Annals of ... (more)

Comment?

Related Topix: Heart Attack, Health, Biotech, Medicine, Marketing

8 hrs ago | Hispanic Business

Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders' Meeting Proposals

ISS provides voting analysis on more than 20,000 shareholder meetings per year to mutual funds, financial institutions and hedge funds.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Pharmaceuticals

Wed Jul 23, 2014

GuruFocus.com

George Soros Reveals His Largest Stake

Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .

Comment?

Related Topix: Securities and Exchange Commission, Corporate / Securities Law, Law, Soros Fund Management, Financial Services, Investment Services, Biotech

SchaeffersResearch.com

Analyst Update: EMC Corporation, Teva Pharmaceutical Industries Ltd...

"I don't know another tech company that has [spun off one of its most strategic assets] and been successful," opined EMC CEO Joe Tucci in a conference call.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Computers, EMC, VMware, Software, Financial Markets, Day Trading, Personal Finance

TheStreet.com

How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Mozilla

Tue Jul 22, 2014

Seeking Alpha

XTL Hopes To Begin Major Lupus Trial Next Year

XTLB is aiming to begin a Phase 2b clinical trial in the first half of 2015 with its hCDR1 peptide to treat patients with SLE.

Comment?

Related Topix: Medicine, Lupus, Health, Biotech

Freshnews

Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot...

Antares Pharma, Inc. today announced that the first patient has been dosed in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot Testosterone administered subcutaneously once each week to testosterone-deficient adult males.

Comment?

Related Topix: Antares Pharma, Medicine, Medical Equipment, Healthcare Industry, Food and Drug Administration, Biotech

Mon Jul 21, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The acquisition of Labrys brings to Teva LBR-101,... )--Mark Cosby joins Office Depot, Inc. as president, North America following a successful 30-year career at a number of leading retail chains.

Comment?

Related Topix: Biotech

San Diego Source

Arena subsidiary enters agreement with Israeli distributor for weight loss drug

Arena Pharmaceuticals Inc . announced on Monday that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement with Abic Marketing Limited, a Teva Pharmaceutical Industries subsidiary, for its weight loss and management product Belviq.

Comment?

Related Topix: Israel, World News, Middle East, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Pharmaceutical Processing

Teva Completes Acquisition of Labrys

Teva Pharmaceutical Industries Ltd. today announced the successful completion of the acquisition of Labrys.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Migraine, Health, Imitrex, Sumatriptan (generic), Headache

Fri Jul 18, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The release will be available at http://investor.firstdata.com.... )--PayMeOn, Inc. today announced it has completed the acquisitions of A Better Bike, LLC and E Bikes, LLC. Together the companies own 19.4% of Prod... )--Kansas City Southern reported second quarter 2014 revenues of $650 million.

Comment?

Related Topix: Forrester Research, Advertising, Werner Co, Industrial Machines, Metals, Redfin, Transportation, Kansas City Southern, Railroads, Biotech

Freshnews

Teva to Report Second Quarter 2014 Financial Results on July 31, 2014

Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2014 financial results on Thursday, July 31, 2014 at 7:00 a.m. ET.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Wed Jul 16, 2014

GuruFocus.com

George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR

George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR George Soros is Chairman of Soros Fund Management LLC, a privately held investment management firm and former hedge fund.

Comment?

Related Topix: Biotech, Energy, Oil & Gas, Equitable Resources, Soros Fund Management, Financial Services, Investment Services, Financial Markets, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Investor's Business Daily

Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other...

Teva Pharmaceutical Industries Ltd., reported today that ISS Proxy Advisory Services, the leading U.S. independent proxy advisory firm, recommended that shareholders vote in favor of all Teva nominees for director Nitzani, Dan Propper and Ory Slonim) and for each of the other proposals on the agenda for consideration at the Company's upcoming ... (more)

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Mon Jul 14, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The acquisition enhance... NanoViricides President Dr. Diwan Presented FluCide Data at the 3rd Annual Influenza Conference held by GTC Bio on Friday, July 11 )--Dr. Diwan presented data on the broad-spectrum anti-influenza drug candidates NV-INF-1 and NV-INF-2 at the GTC Bio Influenza Conference on Fr... )--Teva Pharmaceuticals Industries Ltd., ... (more)

Comment?

Related Topix: Marketing, Medicine, Influenza, Health, Biotech, Food and Drug Administration, World Fuel Services Corporation, Energy, Oil & Gas

West Australian

Teva to name new chairman - activist investor Landa says

"I was informed ... by Moshe Many, Amir Elstein's predecessor as vice chairman, that the board has already decided that it will name Amir Elstein as the next chairman," Landa wrote in a blog.

Comment?

Related Topix: Biotech

Investor's Business Daily

Teva Announces FDA Acceptance of NDA Filing for Investigational...

Teva Pharmaceuticals Industries Ltd., announced today that the U.S. Food and Drug Administration has accepted for review the company's new drug application for albuterol multi-dose dry-powder inhaler , an investigational breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with ... (more)

Comment?

Related Topix: Biotech, Medicine, Food and Drug Administration, Albuterol (generic), Ventolin, Proventil, Asthma, Health

AmericanBankingNews.com

Teva Pharmaceutical Industries Ltd Given Consensus Recommendation of...

Teva Pharmaceutical Industries Ltd has earned an average rating of "Buy" from the twenty-four analysts that are presently covering the company, AnalystRatingsNetwork reports .

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Fri Jul 11, 2014

Pharmacy Times

Generic Product News

Omega-3-Acid Ethyl Esters Capsules, USP, Marketed by: Teva Pharmaceutical Industries Ltd Compare to: Lovaza Indication: Teva Pharmaceutical Industries Ltd announces the approval of Omega-3-Acid Ethyl Esters Capsules, USP, a generic equivalent to GlaxoSmithKline's Lovaza.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, GlaxoSmithKline, Dovonex, Calcipotriene (generic), Betamethasone (generic), Diprolene

SBWire

Transition at Teva: Blockbuster Drug Copaxone to Lose Patent Protection in 2014 - New Market Report

In October 2013, Teva announced that it would be cutting approximately 10% of the workforce in order to cut costs.

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••